U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07890493) titled 'Immune Checkpoint Blockade and Chemotherapy With or Without Fecal Microbiota Transplant in Advanced Non-Small Cell Lung Cancer' on Oct. 16.

Brief Summary: This study is being done to answer the following question: Can adding a treatment called Fecal Microbiota Transplant (FMT) to the usual treatment delay the growth or spread of cancer better than the usual treatment alone? FMT treatment changes the bacteria in the gut called the microbiome.

Study Start Date: Dec. 31

Study Type: INTERVENTIONAL

Condition: Non Small Cell Lung Cancer

Intervention: BIOLOGICAL: LND101

Assigned at enrollment

DRUG: Carboplatin (AUC 5 or 6)

Standar...